Post-Electrophysiology Mortality Usually Not Related to Procedure

This article originally appeared here.
Share this content:
Post-Electrophysiology Mortality Usually Not Related to Procedure
Post-Electrophysiology Mortality Usually Not Related to Procedure

WEDNESDAY, Feb. 18, 2015 (HealthDay News) -- Half of major complications within 30 days of electrophysiology (EP) procedures occur after discharge, but the majority of deaths are not directly related to the procedure, according to a study published online Feb. 14 in the Journal of Cardiovascular Electrophysiology.

Sarah K. Hussain, M.D., from the Penn State Hershey Medical Center, and colleagues characterized the incidence and timing of adverse events up to 30 days after EP procedures at a tertiary academic medical center. All patients undergoing EP procedures between January 2010 and September 2012 were followed for 30-days post-procedure.

Data were included for 3,213 procedures. The researchers observed major complications in 2.2 percent of patients, and about half of these (49 percent) occurred after discharge. Overall, 0.6 percent of patients died; 73 percent of deaths were unrelated to the procedure, and were secondary to worsening of the patient's underlying comorbid conditions.

"In our cohort, half of major complications occurring within 30 days occurred after discharge," the authors write. "In addition, three quarters of deaths within 30 days were not directly related to the procedure and caution should be used in using all-cause mortality as an outcome measure for EP procedures."

Several authors disclosed financial ties to the pharmaceutical and medical device industries.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »